Plain-English translation of NCT05104710 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This research is testing a new tool called intermuscular coherence (IMC) that measures how well two muscles work together during a simple movement. Doctors think this quick, painless test could help them diagnose ALS earlier and more reliably than current methods. The study will involve about 650 people across multiple medical centers.
Right now, diagnosing ALS takes a long time because doctors don't have an objective test they can rely on — they have to wait and watch symptoms develop. This medication or treatment is hindered by the lack of clear, measurable markers of the disease. If this muscle test works, it could speed up diagnosis and help doctors track whether treatments are working.
You likely qualify if…
You likely don't qualify if…
During your visit, researchers will place small surface electrodes on your skin to measure how your muscles communicate during simple movements — this is quick, painless, and non-invasive. You'll also complete a standard neurological exam and answer questions about your symptoms. If you're in the follow-up portion of the study, you may be measured again six months later to see if the test can track disease progression. The entire process takes place in a standard neurology clinic and does not involve any medications or invasive procedures.
AI-generated summary from trial data · Jun 1, 2026 · Not medical advice
United States